Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Primary Breast Cancer”

62 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 62 results

Testing effectiveness (Phase 2)Ended earlyNCT01919229
What this trial is testing

A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)

Who this might be right for
Early Breast Cancer
Novartis Pharmaceuticals 14
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Very early researchEnded earlyNCT04102618
What this trial is testing

A Window-of-opportunity Study of Pelareorep in Early Breast Cancer

Who this might be right for
Breast Cancer
Oncolytics Biotech 26
Large-scale testing (Phase 3)Study completedNCT02214381
What this trial is testing

A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response

Who this might be right for
Early Primary Breast Cancer
West German Study Group 80
Large-scale testing (Phase 3)WithdrawnNCT00888082
What this trial is testing

Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy

Who this might be right for
Breast CancerOvarian Function
AstraZeneca 102
Testing effectiveness (Phase 2)Study completedNCT00247650
What this trial is testing

Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Novartis 190
Early research (Phase 1)Active Not RecruitingNCT01366144
What this trial is testing

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Who this might be right for
Breast CarcinomaCarcinoma of Unknown PrimaryEndometrial Carcinoma+11 more
National Cancer Institute (NCI) 94
Testing effectiveness (Phase 2)Study completedNCT00422903
What this trial is testing

Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 92
Not applicableStudy completedNCT02125019
What this trial is testing

Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Ohio State University Comprehensive Cancer Center 62
Testing effectiveness (Phase 2)Study completedNCT00429299
What this trial is testing

Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 121
Large-scale testing (Phase 3)Study completedNCT01049425
What this trial is testing

Anthracycline-free Taxane Based Chemotherapy in Patients With HER2/Neu Negative Early Breast Cancer

Who this might be right for
Primary Breast CancerHer2 Non-overexpressing
West German Study Group 3,198
Post-approval studies (Phase 4)Study completedNCT02816164
What this trial is testing

Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia

Who this might be right for
Early Stage Breast Cancer
Ottawa Hospital Research Institute 324
Not applicableActive Not RecruitingNCT05926024
What this trial is testing

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 253
Very early researchWithdrawnNCT05368506
What this trial is testing

ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Ovarian CarcinomaAdvanced Primary Peritoneal Carcinoma+8 more
OHSU Knight Cancer Institute
Not applicableLooking for participantsNCT07190066
What this trial is testing

MELIORA Data Collection Campaigns

Who this might be right for
Breast Cancer Prevention
Harokopio University 300
Not applicableLooking for participantsNCT05071105
What this trial is testing

SBRT in Early Breast Cancer in Elderly Women

Who this might be right for
Breast Neoplasm Female
University of Rome Tor Vergata 30
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Testing effectiveness (Phase 2)Ended earlyNCT00162812
What this trial is testing

Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin

Who this might be right for
Breast Cancer
Jules Bordet Institute 338
Large-scale testing (Phase 3)Ended earlyNCT00429403
What this trial is testing

Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 1
Not applicableStudy completedNCT02664389
What this trial is testing

Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation

Who this might be right for
Breast CancerOvarian CancerColorectal Cancer+2 more
University Hospital, Rouen 289
Load More Results